drugset / Trial / NCT02500212

Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

NCT02500212 ↗

Phase 4 Completed 75 enrolled Chiesi Farmaceutici S.p.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

Open-label, multicentre, randomized clinical trial to compare the pharmacokinetics of ENVARSUS® tablets and ADVAGRAF® capsules administered once daily in adult de-novo kidney transplant patients.

Timeline

Start
2015-07
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule 0.17 mg/kg Oral
Comparator Tacrolimus Small molecule 0.2 mg/kg Oral